Drug Shortage Report for ODAN-SPOR-HC

Last updated on 2017-10-05 History
Report ID 1041
Drug Identification Number 00626600
Brand name ODAN-SPOR-HC
Common or Proper name Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP
Company Name ODAN LABORATORIES LTD
Market Status DORMANT
Active Ingredient(s) Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate
Strength(s) 10 mg/mL 3.5 mg/mL 10,000 unit/mL
Dosage form(s) Suspension
Route of administration Otic
Packaging size 10 mL
ATC code S02CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-04-15
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2017-10-05
Company comments
Health Canada comments
Tier 3 Status No
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 2 of 2